7th July 2011
UK firms shine at BIO 2011
The following is a guest blog by Spencer Mahony, HM Consul & UKTI Regional Director for the South East US, British Embassy Washington.
The convention floor pavilion was just a part of our work around BIO 2011. We hosted a breakfast here at the Embassy for Canadian and Australian delegation members to network and meet potential UK partners. Our event for corporate-level executives on Tuesday, held at the intriguing International Spy Museum, was extremely well attended; the Embassy’s Deputy Head of Mission, Philip Barton, addressed the attendees and pushed home our key messages about the UK’s world class science base and excellent reputation for drug discovery.
The high interest in biotech partnerships with UK firms comes as no surprise; after all, the UK is one of the world’s premier locations for life science work. Indeed the medical biotechnology sector in the UK is vibrant with over 900 companies in this sector and a turnover of more than £5.5bn. The UK is also home to a full tenth of all the world’s research and development funding. Our universities are among the best in the world, and produce a high proportion of the top researchers: 70 Nobel Prize winners in scientific disciplines have UK roots.
Biotechnology in the UK continues to excite the biomedical research community. Businesses are bringing new products to market and announcing major breakthroughs all the time. New initiatives from the UK Government continue to make the UK the place to do business. These include higher tax relief on R&D which will be rising to 225% by April 2012. A new preferential regime for profits arising from patents, ‘a Patent box’, which will also provide a reduced rate of corporation tax, 10%, from patents held in the UK. The UK remains the best place in Europe to do business.
The UK is open for business for biotech investment. And thanks to the tremendous work of our staff and partners at BIO 2011, this message was delivered to BIO attendees loud and clear. Now the exciting work of facilitating the partnerships and investments begins.